guanylate cyclase-C agonist

Linaclotide companies

Answer

Public registers name 3 licence holders, 16 ingredient makers with a drug master file, 8 bulk ingredient labelers, 1 US labeler, 26 trial sponsors and 1 recalling firm for Linaclotide.

Each row is what a register states. A company named here is not endorsed or accused by this site.

MARKETING AUTHORISATION HOLDER

3 companies

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

ABBVIE CORPORATION
CONSTELLA (DIN 02417162), Marketed Regulator Health Canada
CONSTELLA (DIN 02417170), Marketed Regulator Health Canada
CONSTELLA (DIN 02469510), Marketed Regulator Health Canada
AbbVie Deutschland GmbH & Co. KG
Constella (EMEA/H/C/002490), Authorised Regulator EMA
ABBVIE LTD
CONSTELLA 290 MICROGRAMS HARD CAPSULES, PLGB 41042/0079, Authorised Regulator MHRA

API MANUFACTURER

16 companies

Filed a drug master file with FDA for the active ingredient.

AURO PEPTIDES LTD
DMF 29708, type II, active, submitted 2015-09-22 Regulator FDA drug master file list
BACHEM AMERICAS INC
DMF 28273, type II, inactive, submitted 2014-05-05 Regulator FDA drug master file list
CHENGDU SHENGNUO BIOPHARM CO LTD
DMF 35812, type II, active, submitted 2021-04-06 Regulator FDA drug master file list
CORDEN PHARMA COLORADO INC
DMF 24992, type II, active, submitted 2011-05-27 Regulator FDA drug master file list
HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD
DMF 42040, type II, active, submitted 2025-06-12 Regulator FDA drug master file list
HANGZHOU THINHEAL PHARMA-TECH CO LTD
DMF 39901, type II, active, submitted 2024-06-28 Regulator FDA drug master file list
HYBIO PHARMACEUTICAL CO LTD
DMF 32314, type II, active, submitted 2017-12-28 Regulator FDA drug master file list
DMF 37370, type II, active, submitted 2022-08-17 Regulator FDA drug master file list
MSN LIFE SCIENCES PRIVATE LTD
DMF 30421, type II, inactive, submitted 2016-03-29 Regulator FDA drug master file list
DMF 31351, type II, active, submitted 2017-02-01 Regulator FDA drug master file list
POLYPEPTIDE LABORATORIES INC
DMF 25025, type II, active, submitted 2011-06-07 Regulator FDA drug master file list
POLYPEPTIDE LABORATORIES SWEDEN AB
DMF 25021, type II, active, submitted 2011-06-01 Regulator FDA drug master file list
Sun Pharmaceutical Industries Ltd.
DMF 30266, type II, active, submitted 2016-11-16 Regulator FDA drug master file list
SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD
DMF 42635, type II, active, submitted 2025-09-23 Regulator FDA drug master file list
TAPI NL BV
DMF 30274, type II, active, submitted 2016-03-10 Regulator FDA drug master file list
WISDOM PHARMACEUTICAL CO LTD
DMF 44235, type II, active, submitted 2026-05-29 Regulator FDA drug master file list
ZHEJIANG PEPTITES BIOTECH CO LTD
DMF 42049, type II, active, submitted 2025-06-08 Regulator FDA drug master file list
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
DMF 43837, type II, active, submitted 2026-03-16 Regulator FDA drug master file list

BULK INGREDIENT LABELER

8 companies

Lists the bulk active ingredient with FDA (NDC directory).

Aurobindo Pharma Limited
Linaclotide, BULK INGREDIENT Regulator openFDA
CHENGDU SHENGNUO BIOPHARM CO LTD
Linaclotide, BULK INGREDIENT Regulator openFDA
CORDEN PHARMA COLORADO INC
linaclotide, BULK INGREDIENT Regulator openFDA
HYBIO PHARMACEUTICAL CO LTD
Linaclotide, BULK INGREDIENT Regulator openFDA
MSN Life Sciences Private Limited
Linaclotide, BULK INGREDIENT Regulator openFDA
POLYPEPTIDE LABORATORIES INC
linaclotide, BULK INGREDIENT Regulator openFDA
SUN PHARMACEUTICAL INDUSTRIES INC
Linaclotide, BULK INGREDIENT Regulator openFDA
Zhejiang SyncoTide Bio-pharmaceutical Co., Ltd
Linaclotide, BULK INGREDIENT Regulator openFDA

US LABELER

1 company

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

Allergan, Inc.
linaclotide, DRUG FOR FURTHER PROCESSING Regulator openFDA
Linzess, NDA Regulator openFDA

TRIAL SPONSOR

26 companies

Sponsors registered clinical trials of the peptide.

Forest Laboratories
9 registered trials Trial register ClinicalTrials.gov
Ironwood Pharmaceuticals, Inc.
9 registered trials Trial register ClinicalTrials.gov
AbbVie
4 registered trials Trial register ClinicalTrials.gov
Astellas Pharma Inc
4 registered trials Trial register ClinicalTrials.gov
AbbVie Deutschland GmbH & Co. KG
2 registered trials Trial register EU CTIS
AstraZeneca
2 registered trials Trial register ClinicalTrials.gov
Mayo Clinic
2 registered trials Trial register ClinicalTrials.gov
University of Nottingham
2 registered trials Trial register ClinicalTrials.gov
Allergan
1 registered trial Trial register ClinicalTrials.gov
Augusta University
1 registered trial Trial register ClinicalTrials.gov
Changhai Hospital
1 registered trial Trial register ClinicalTrials.gov
Haifeng Lan
1 registered trial Trial register ClinicalTrials.gov
Jiangsu Hansoh Pharmaceutical Co., Ltd.
1 registered trial Trial register ClinicalTrials.gov
McMaster University
1 registered trial Trial register ClinicalTrials.gov
Md Mehedi Shahriar
1 registered trial Trial register ClinicalTrials.gov
RenJi Hospital
1 registered trial Trial register ClinicalTrials.gov
Second Affiliated Hospital of Xi'an Jiaotong University
1 registered trial Trial register ClinicalTrials.gov
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
1 registered trial Trial register ClinicalTrials.gov
Texas Tech University Health Sciences Center, El Paso
1 registered trial Trial register ClinicalTrials.gov
TriHealth Inc.
1 registered trial Trial register ClinicalTrials.gov
Universitaire Ziekenhuizen KU Leuven
1 registered trial Trial register ClinicalTrials.gov
University of Florida
1 registered trial Trial register ClinicalTrials.gov
University of Virginia
1 registered trial Trial register ClinicalTrials.gov
University of Wisconsin, Madison
1 registered trial Trial register ClinicalTrials.gov
Wingate Institute of Neurogastroenterology
1 registered trial Trial register ClinicalTrials.gov
Zhiguo Liu
1 registered trial Trial register ClinicalTrials.gov

RECALLING FIRM

1 company

Recalled a product naming the peptide (FDA enforcement report).

Cardinal Health Inc.
Class II recall, Terminated, 2021-06-02 Regulator openFDA

Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings. Trade between countries in all polypeptide hormones, Linaclotide among them: trade.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.